Rare Diseases >> Abstract Details   Synthetic Vaccine Against P. falciparum Malaria Description of Invention: A synthetic vaccine is available for testing against P. falciparum malaria. Control of malarial disease has been achieved on a limited basis in certain parts of the world; however, no vaccine presently exists that can provide protective immunity. This synthetic vaccine contains a peptide which induces the activation of cytotoxic T cells that specifically recognize and kill cells infected with malaria sporozoites. Inventors: Michael F. Good (NIAID) et al. Patent Status: DHHS Reference No. E-226-1988/0 -- U.S. Patent No. 5,028,425 issued 02 Jul 1991 Portfolios: Infectious Diseases Infectious Diseases -Vaccines-Parasitic Infectious Diseases -Vaccines For Additional Information Please Contact: Robert M. Joynes J.D. NIH Office of Technology Transfer 6011 Executive Blvd, Suite 325 Rockville, MD 20852-3804 Phone: (301)594-6565 Email: joynesr@mail.nih.gov Fax: (301) 402-0220 Web Ref: 1188 Last Updated On: 11/91